Health

Bispecifics Before CAR-T May Be Best-Bet Sequence for Large B-Cell Lymphoma

TribeNews
By TribeNews 3 Views Add a Comment
0 Min Read
Bispecifics Before CAR-T May Be Best-Bet Sequence for Large B-Cell Lymphoma

MedPage Today) — The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal treatment sequence than BsAb after CAR-T in patients with relapsed or refractory large B-cell lymphoma…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app